Webinars

SCLC's webinar series is integral to the technical assistance provided by the SCLC. Nationally recognized smoking cessation experts offer the latest information related to smoking cessation (including effective interventions) for the general and the behavioral health populations.

The Goals of SCLC’s Webinar Series:

  • Provide training and technical assistance to raise awareness of the many benefits smoking cessation efforts and to increase understanding of effective smoking cessation strategies.
  • Implement or enhance existing tobacco cessation services using evidence-based practices.
  • Ensure that consumers and staff have access to smoking cessation services and support to promote health and wellness.
  • Establish partnerships between behavioral health and nicotine cessation organizations to increase available tobacco cessation resources in communities. 

SCLC has over 100 webinars covering the latest topics on tobacco addiction and recovery

 

Current Webinars

Tobacco Cessation From Evidence to Practice: Contingency Management for People Experiencing Homelessness

-

Speakers

Maya Vijayaraghavan, MD, MAS

Director, Smoking Cessation Leadership Center, University of California, San Francisco, Steven A. Schroeder Distinguished Professor of Health and Health Care, Associate Professor of Medicine

Maya is a practicing general internist and a researcher in tobacco control with a focus on populations experiencing homelessness. Her work in the last decade has helped quantify tobacco use among marginalized communities and has led to interventions to improve smoke-free policies and access to cessation services in these populations. 

 

Her intervention research involves deep collaboration with health systems and community organizations and has been supported by the Tobacco Related Disease Research Program (TRDRP), the National Cancer Institute (NCI), and the San Francisco Cancer Initiative, as well as many others. 

 

She earned her medical degree from Boston University, completed a residency in internal medicine at Columbia University in New York and earned her Master of Applied Science degree from UCSF. 

In addition to her role as the director of the SCLC, Maya also serves as the co-director of the UCSF Center for Tobacco Control Research and Education postdoctoral training program. She will continue her clinical work at the Richard H. Fine People’s Clinic at the Zuckerberg San Francisco General Hospital. 

Webinar Objectives:

  1. Describe the epidemiology of tobacco use behaviors
  2. Describe two tobacco-related inequities
  3. Discuss all of the results from a randomized controlled contingency management (CM) intervention trial for smoking cessation
  4. Discuss two policy and practice implications for CM for tobacco use

Upcoming Webinars

Navigating the Intersection of Tobacco and Opioid Use Disorder

-

Speakers

Shadi Nahvi, MD, MS

Professor, Departments of Medicine, and of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine / Montefiore Health System

Dr. Shadi Nahvi is Professor (with tenure) in the Departments of Medicine and Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, and directs the General Internal Medicine and Addiction Medicine Fellowship Programs.  Her research focuses on optimizing quality of life and health outcomes among persons with substance use disorder.

Dr. Nahvi’s research is grounded in nearly two decades of clinical experience as a primary care physician caring for persons with opioid and other substance use disorders. Her primary research focus is optimizing the efficacy and delivery of tobacco cessation treatments among persons with co-occurring substance use disorders. Currently, she is Principal Investigator of a NIDA R01-funded randomized, 2 x 2 factorial trial of directly observed and long-term varenicline treatment among smokers with opioid use disorder. She has also led a KL2 Career Development Award-funded, randomized, placebo-controlled pilot trial of varenicline for smoking cessation among smokers with co-morbid substance use disorder, a study of health system-level interventions to increase documentation and treatment of tobacco use among substance use disorder counselors, and a randomized trial of the efficacy of directly observed varenicline provided at a methadone clinic for promoting smoking cessation and enhancing adherence. 

Dr. Nahvi graduated from the Brown University School of Medicine in 2001 and completed residency training in Primary Care Internal Medicine at Bellevue Hospital and New York University Medical Center in 2004.  She then joined the faculty in the Albert Einstein College of Medicine Division of Substance Abuse as the Medical Director of an opioid treatment program. From 2006-2008, Dr. Nahvi completed a faculty fellowship supported by the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities and received a MS in Clinical Research Methods. 

Dr. Nahvi has served on numerous national advisory committees, including serving as a member of the Advisory Committee of the Society for Research on Nicotine and Tobacco Health Disparities Network, and co-chair of the Evaluation Committee of the Health Disparities Network; a member of the NY State Department of Health AIDS Institute’s Guideline Committee for the Care of Substance Users; and a Steering Committee member of the NY State Department of Health AIDS Institute's Tobacco Cessation Improvement Campaign.

Webinar Objectives:

  1. Explain the burden of tobacco use among people with opioid use disorder
  2. Describe the importance of treating tobacco use among people with opioid use disorder
  3. Describe two treatments and health system strategies to address tobacco use among people with opioid use disorder